Federal contractor · PEABODY, MA

PRIVO TECHNOLOGIES, INC.

No contract obligations recorded for PRIVO TECHNOLOGIES, INC. in FY2026. Since FY2022: $2M. It also received $1.2M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
E6ACGUBJMQC5
Small businessWoman-ownedMinority-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 2MFY2022
  2. 0FY2023

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for PRIVO TECHNOLOGIES, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

PRIVO TECHNOLOGIES, INC. received $1.2M in federal assistance in FY2026, on 2 actions (0 new awards), −6.1% vs FY2025. Its largest program was 93.395 · Cancer Treatment Research ($1.2M).

Assistance · FY2026
$1.2M
New awards
0
Actions
2
Since FY2021
$9.9M

Assistance by fiscal year

  1. 1.3MFY2021
  2. 1.2MFY2022
  3. 2MFY2023
  4. 3.1MFY2024
  5. 1.2MFY2025
  6. 1.2MFY2026

By type

  1. Grants$1.2M100%

Top programs

  1. 93.395 · Cancer Treatment Research$1.2M100%

Awarding agencies

  1. National Institutes of Health$1.2M100%
    Department of Health and Human Services

Largest awards

  1. SUPPORT FOR REGISTRATION ENABLING PHASE 3 CLINICAL TRIAL FOR NANOTECHNOLOGY-BASED TREATMENT OF CARCINOMA IN SITU OF THE ORAL CAVITY (STAGE…$4.5M
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Jun 14, 2024 – Jun 18, 2026· R44CA281020
  2. CLINICAL STUDIES FOR IMPROVING SURVIVAL RATES FOR ORAL CANCER PATIENTS IN LOW RESOURCE SETTINGS - PROJECT SUMMARY ORAL CANCER (OC) IS AN…$2.4M
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Feb 24, 2022 – Aug 21, 2026· R44CA272095

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.